SMART MONEY GROUP

[StockHighAlert-]

$RGBP recently identified a key structural element whose presence in small molecules seems to be required for activation of NR2F6. In order to ensure that we capture as much intellectual property as possible, we screened a new 48,000 compound library containing diverse compounds," says Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen. "In doing so, we identified 25 new compounds that activate NR2F6. Remarkably, each newly-identified compound contained the key structure that we previously identified. This tells us that it is likely the key structural element we identified is an absolute requirement for activating NR2F6. We anticipate utilizing our three-dimensional x-ray crystallography program to attempt to provide a clear molecular picture of this recently identified element. http://www.stockonhighalert.net/2018/01/rgbp-regen-biopharma-incs-medicinal.html